11-124023274-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001001953.1(OR10G9):c.262G>A(p.Gly88Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000106 in 1,571,484 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001953.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR10G9 | NM_001001953.1 | c.262G>A | p.Gly88Ser | missense_variant | 1/1 | ENST00000375024.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR10G9 | ENST00000375024.1 | c.262G>A | p.Gly88Ser | missense_variant | 1/1 | NM_001001953.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000931 AC: 14AN: 150344Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.000118 AC: 27AN: 229650Hom.: 0 AF XY: 0.000153 AC XY: 19AN XY: 124516
GnomAD4 exome AF: 0.000108 AC: 153AN: 1421024Hom.: 0 Cov.: 33 AF XY: 0.000115 AC XY: 81AN XY: 705498
GnomAD4 genome AF: 0.0000930 AC: 14AN: 150460Hom.: 0 Cov.: 28 AF XY: 0.0000681 AC XY: 5AN XY: 73414
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 14, 2023 | The c.262G>A (p.G88S) alteration is located in exon 1 (coding exon 1) of the OR10G9 gene. This alteration results from a G to A substitution at nucleotide position 262, causing the glycine (G) at amino acid position 88 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at